Subscribe

Spotlight -

This Year In Medicine 2025

James Januzzi, MD

Articles by James Januzzi, MD

Role of Genetic Mutations in HCM Pathophysiology

ByJames Januzzi, MD,Steve R. Ommen, MD,John A. Spertus, MD, MPH,Martin S. Maron, MD,Javed Butler, MD, MPH, MBA

May 6th 2022

Steve R. Ommen, MD, leads a review of common mutations seen in hypertrophic cardiomyopathy and the role of biomarkers and genetic testing in HCM.

Overview of Hypertrophic Cardiomyopathy

ByJames Januzzi, MD,Steve R. Ommen, MD,John A. Spertus, MD, MPH,Martin S. Maron, MD,Javed Butler, MD, MPH, MBA

May 6th 2022

Martin S. Maron, MD, discusses the incidence and prevalence of hypertrophic cardiomyopathy and age of disease expression.

Trending on HCPLive

Lp(a) HORIZON Shows Pelacarsen Lowers Lp(a) 78% But Not Cardiovascular Events

Cannabis Use Tied to Higher Odds of Stroke, Cardiovascular Disease

AHA 2026: Intensive Blood Pressure Control Reduces Events After Ischemic Stroke

Common Diuretic Linked to Home Blood Pressure Lowering After Stroke

STREAM: Statin Discontinuation Noninferior in Older Adults Without CVD